RxDoctor Payments DataLook up a doctor →

Lance Chapman

MOHS-Micrographic Surgery · Los Angeles, CANPI 1194143438

Payments from drug & device makers

$10,583in general payments, 2019–2025

Across 464 payments — averaging $22.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Amgen$1K
  • Sanofi$1K
  • Regeneron Healthcare Solutions, Inc.$904
  • Johnson & Johnson$734
  • UCB, Inc.$456
  • plus $3K from 27 others

What the payments were for

  • Food & beverage$10,42498%
  • Education$1592%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,583 in reported general payments places this provider in the 80th percentile of 144 mohs-micrographic surgery providers in California.

See all mohs-micrographic surgery providers in California

Medicare billing

Part B allowed, 2024
$2,024,809
Medicare patients
677
Services billed
9,447

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab13$67,625
Doxycycline Hyclate72$1,909
Clobetasol Propionate26$1,398
Doxycycline Monohydrate224$1,323
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip50$1,114
Ketoconazole74$1,010
Metronidazole25$904
ValacyclovirValacyclovir Hcl28$873
Fluocinolone Acetonide19$833
Fluocinonide17$605
Mupirocin83$569
Triamcinolone Acetonide35$389
Fluorouracil14$376
Clindamycin Phosphate11$191
Prednisone20$125

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →